NCT06686901

Brief Summary

This study aims to evaluate the acceptability, safety, and efficacy of a smartphone-delivered intervention called Therapeutic Evaluative Conditioning for Suicide (TEC-S) in reducing suicidal thoughts and behaviors (STB) among adults with recent and frequent suicide ideation.

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
29mo left

Started Apr 2027

Typical duration for not_applicable

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 12, 2024

Completed
1 day until next milestone

First Posted

Study publicly available on registry

November 13, 2024

Completed
2.4 years until next milestone

Study Start

First participant enrolled

April 1, 2027

Expected
2.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2029

2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

August 31, 2029

Last Updated

January 26, 2026

Status Verified

January 1, 2026

Enrollment Period

2.3 years

First QC Date

November 12, 2024

Last Update Submit

January 22, 2026

Conditions

Keywords

Suicideecological momentary assessment (EMA)Therapeutic Evaluative Conditioning (TEC)

Outcome Measures

Primary Outcomes (1)

  • Desire to die by suicide (Likert)

    Right now, how strongly do you want to kill yourself? \[0 (not at all) to 10 (extremely)\]; assessed via 3x/day ecological momentary assessment (Kleiman et al., 2018)

    Through completion of treatment phase (day 1 through 30)

Secondary Outcomes (10)

  • Suicide intent (Likert)

    Through completion of treatment phase (day 1 through 30)

  • Suicide urge (Likert)

    Through completion of treatment phase (day 1 through 30)

  • Suicide thought incidence

    Through treatment phase completed (day 1 through 30)

  • Suicide planning incidence

    Through completion of treatment phase (day 1 through 30)

  • Suicide preparation incidence

    Through completion of treatment phase (day 1 through 30)

  • +5 more secondary outcomes

Study Arms (2)

Smartphone-delivered inactive Therapeutic Evaluative Conditioning (inactive TEC)

PLACEBO COMPARATOR

Optional smartphone-delivered inactive Therapeutic Evaluative Conditioning (inactive TEC) for 30 days.

Behavioral: Smartphone-delivered inactive Therapeutic Evaluative Conditioning

Smartphone-delivered active Therapeutic Evaluative Conditioning for Suicide (active TEC)

EXPERIMENTAL

Optional smartphone-delivered active Therapeutic Evaluative Conditioning for Suicide (active TEC-S) for 30 days.

Behavioral: Smartphone-delivered Therapeutic Evaluative Conditioning for Suicide (TEC-S)

Interventions

Therapeutic Evaluative Conditioning for Suicide (active TEC-S) is a behavioral treatment where participants are given optional access to a computerized task/game where they repeatedly pair suicidal behavior stimuli (pictures, words) with other negative stimuli and self-related stimuli with positive stimuli.

Smartphone-delivered active Therapeutic Evaluative Conditioning for Suicide (active TEC)

Therapeutic Evaluative Conditioning (inactive TEC-S) is a behavioral treatment where participants are given optional access to a computerized task/game where they repeatedly pair positive and negative stimuli (pictures, words) with each other.

Smartphone-delivered inactive Therapeutic Evaluative Conditioning (inactive TEC)

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adults ages 18+
  • Relatively frequent and recent (≥5 days within the past-month) active suicidal thoughts as assessed via SITBI-R.
  • Willing and able to provide at least one emergency contact (name, phone number, relation).
  • Owns an Android or iOS smartphone.
  • Possesses at least occasional access to Wi-Fi-enabled internet for data down/uploads.
  • Fluent in English and willing to provide informed consent.
  • Living in the Boston metropolitan area (i.e., \~50 mile radius around Boston, MA)

You may not qualify if:

  • Recent (past 3-month) hypo/manic symptoms or homicidal ideation or lifetime psychosis spectrum diagnosis as assessed via MINI 7.0.2.
  • Recent acute suicide risk operationalized as affirmative responses to BOTH below items during structured clinical interview AND evaluation by the PI in consultation with Mentors/Advisor Drs. Wilhelm, Kleiman, and/or Bentley:
  • At any time in past week: ≥ 8/10 current intent to act on suicidal thoughts (0 \["not at all"\] to 10 \["extremely strong"\]); AND
  • At any time in past week: thought of a specific suicide plan (i.e, known method/means and/or location) with access to lethal means
  • Impaired vision (e.g., legal blindness), technological illiteracy, or intellectual disability that might impair ability to provide valid data and/or informed consent.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Suicidal IdeationSuicide, AttemptedSuicide

Condition Hierarchy (Ancestors)

Self-Injurious BehaviorBehavioral SymptomsBehavior

Central Study Contacts

Adam C Jaroszewski, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

November 12, 2024

First Posted

November 13, 2024

Study Start (Estimated)

April 1, 2027

Primary Completion (Estimated)

July 1, 2029

Study Completion (Estimated)

August 31, 2029

Last Updated

January 26, 2026

Record last verified: 2026-01